Mary Ann Cloyd

CIK 1666769 · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$928.9K

Companies

3

Total Filings

53

Lifetime Open-Market Net

-$91.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FDP Director 31,878 $29.14 $928.9K -$91.0K 38 2026-05-06
ChronoScale Corp (EKSO) Delisted Director 456,707 $11.80 $5.39M $0 6 2025-05-19
Bellerophon Therapeutics, Inc. (BLPH) Delisted Director 21,858 $0.01 $262 $0 9 2023-06-09

Recent Filings · Page 2 of 6

53 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-05-07 FDP Exer (M) +5,857 $0 EDGAR
2024-04-02 FDP Grant (A) $0 EDGAR
2024-02-29 FDP Grant (A) $0 EDGAR
2023-12-12 FDP Grant (A) $0 EDGAR
2023-09-12 FDP Grant (A) $0 EDGAR
2023-06-27 ChronoScale Corp (EKSO) Delisted Grant (A) +67,392 $0 EDGAR
2023-06-16 ChronoScale Corp (EKSO) Delisted Grant (A) +72,993 $0 EDGAR
2023-06-13 FDP Grant (A) $0 EDGAR
2023-06-09 Bellerophon Therapeutics, Inc. (BLPH) Delisted Grant (A) $0 EDGAR
2023-05-08 FDP Mixed +5,998 $0 EDGAR
Showing 1120 of 53
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.